Ivan Millard

Epidemiology of respiratory viral infections among hematopoietic cellular therapy and chimeric antigen receptor T-cell therapy recipients in the post COVID-19 era

Respiratory viral infections (RVIs) remain a source of morbidity among hematopoietic cell transplant (HCT) or chimeric antigen receptor (CAR) T-cell therapy recipients. This study aims to understand the post-pandemic RVI epidemiology in cellular therapy recipients. IRB-approved r...